The prevalence of selected clinically significant red blood cell antigens among Australian blood donors
Pathology · 2024
DOI: 10.1016/j.pathol.2023.10.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology, 2024. Verfasst von Rena Hirani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Australian Red Cross Lifeblood, Sydney, NSW, Australia; Macquarie University, Sydney, NSW, Australia. Electronic address: rhirani@redcrossblood.org.a…. Hauptthemen laut MEDLINE: Blood Donors, Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Red Cross Lifeblood, Sydney, NSW, Australia; Macquarie University, Sydney, NSW, Australia. Electronic address: rhirani@redcrossblood.org.au.
- Australian Red Cross Lifeblood, Brisbane, Qld, Australia.
- Australian Red Cross Lifeblood, Sydney, NSW, Australia.
- Australian Red Cross Lifeblood, Sydney, NSW, Australia; University of Technology Sydney, Sydney, NSW, Australia.
Zitieren
APA
Hirani, R., Powley, T., Mondy, P., & Irving, D. O. (2024). The prevalence of selected clinically significant red blood cell antigens among Australian blood donors. Pathology. https://doi.org/10.1016/j.pathol.2023.10.008
Vancouver
Hirani R, Powley T, Mondy P, Irving DO. The prevalence of selected clinically significant red blood cell antigens among Australian blood donors. Pathology. 2024. doi:10.1016/j.pathol.2023.10.008
BibTeX
@article{Hirani2024,
author = {Hirani, Rena and Powley, Tanya and Mondy, Phillip and Irving, David O},
title = {The prevalence of selected clinically significant red blood cell antigens among Australian blood donors},
journal = {Pathology},
year = {2024},
doi = {10.1016/j.pathol.2023.10.008}
}
EUVIMED